$1.38
▲ +3.8% Today
as of Jul 23, 12:08 ET
Last 30 days
Recent Press Releases & News
Purple Biotech Presents New IM1240 Preclinical Data Showing Anti-Tumor Activity and Broad Therapeutic Window (PPBT)
Purple Biotech Says Preclinical Study Supports Advancing IM1240 to First-in-Human Trial in 2027
Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window
Overview
52-week range
$2.52
$29
0% of range
Avg surprise (last 2)
+3.6%
Avg reaction (last 2)
+2.6%
50% positive
Latest IV / EM
2299%
EM ±254.0% · $3 · Jul 17
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 15, 2026 | Mar/2026 | $-0.09 | $-3.80 | +97.6% | +47.1% | +6.8% | earnings |
| Wed Aug 6, 2025 | Jun/2025 | $-0.40 | $-0.21 | -90.5% | — | — | earnings |
| Wed May 21, 2025 | Mar/2025 | $-0.17 | — | — | — | -1.7% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | OTHER | -$0.98 | $4.00 | -124.5% |